432 related articles for article (PubMed ID: 28029071)
1. Predicting Citrullination Sites in Protein Sequences Using mRMR Method and Random Forest Algorithm.
Zhang Q; Sun X; Feng K; Wang S; Zhang YH; Wang S; Lu L; Cai YD
Comb Chem High Throughput Screen; 2017; 20(2):164-173. PubMed ID: 28029071
[TBL] [Abstract][Full Text] [Related]
2. Prediction of Citrullination Sites on the Basis of mRMR Method and SNN.
Liu M; Liu G
Comb Chem High Throughput Screen; 2019; 22(10):705-715. PubMed ID: 31782357
[TBL] [Abstract][Full Text] [Related]
3. The human peptidylarginine deiminases type 2 and type 4 have distinct substrate specificities.
Assohou-Luty C; Raijmakers R; Benckhuijsen WE; Stammen-Vogelzangs J; de Ru A; van Veelen PA; Franken KL; Drijfhout JW; Pruijn GJ
Biochim Biophys Acta; 2014 Apr; 1844(4):829-36. PubMed ID: 24594197
[TBL] [Abstract][Full Text] [Related]
4. Protein Arginine Deiminases (PADs): Biochemistry and Chemical Biology of Protein Citrullination.
Mondal S; Thompson PR
Acc Chem Res; 2019 Mar; 52(3):818-832. PubMed ID: 30844238
[TBL] [Abstract][Full Text] [Related]
5. Analysis and Prediction of Myristoylation Sites Using the mRMR Method, the IFS Method and an Extreme Learning Machine Algorithm.
Wang S; Zhang YH; Huang G; Chen L; Cai YD
Comb Chem High Throughput Screen; 2017; 20(2):96-106. PubMed ID: 28000567
[TBL] [Abstract][Full Text] [Related]
6. Methylation of arginine residues interferes with citrullination by peptidylarginine deiminases in vitro.
Raijmakers R; Zendman AJ; Egberts WV; Vossenaar ER; Raats J; Soede-Huijbregts C; Rutjes FP; van Veelen PA; Drijfhout JW; Pruijn GJ
J Mol Biol; 2007 Apr; 367(4):1118-29. PubMed ID: 17303166
[TBL] [Abstract][Full Text] [Related]
7. Citrullination and PAD Enzyme Biology in Type 1 Diabetes - Regulators of Inflammation, Autoimmunity, and Pathology.
Yang ML; Sodré FMC; Mamula MJ; Overbergh L
Front Immunol; 2021; 12():678953. PubMed ID: 34140951
[TBL] [Abstract][Full Text] [Related]
8. Citrullinated proteins in rheumatoid arthritis.
Yamada R; Suzuki A; Chang X; Yamamoto K
Front Biosci; 2005 Jan; 10():54-64. PubMed ID: 15574347
[TBL] [Abstract][Full Text] [Related]
9. Peptidylarginine deiminases and deiminated proteins at the epidermal barrier.
Cau L; Méchin MC; Simon M
Exp Dermatol; 2018 Aug; 27(8):852-858. PubMed ID: 29756256
[TBL] [Abstract][Full Text] [Related]
10. Porphyromonas gingivalis peptidylarginine deiminase substrate specificity.
Abdullah SN; Farmer EA; Spargo L; Logan R; Gully N
Anaerobe; 2013 Oct; 23():102-8. PubMed ID: 23856045
[TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of citrulline-modified brain proteins by combining HCD and CID fragmentation.
Jin Z; Fu Z; Yang J; Troncosco J; Everett AD; Van Eyk JE
Proteomics; 2013 Sep; 13(17):2682-91. PubMed ID: 23828821
[TBL] [Abstract][Full Text] [Related]
12. Role of Peptidylarginine Deiminase 4 in Central Nervous System Diseases.
Geng H; An Q; Zhang Y; Huang Y; Wang L; Wang Y
Mol Neurobiol; 2023 Nov; 60(11):6748-6756. PubMed ID: 37480499
[TBL] [Abstract][Full Text] [Related]
13. Citrullination of CXCL10 and CXCL11 by peptidylarginine deiminase: a naturally occurring posttranslational modification of chemokines and new dimension of immunoregulation.
Loos T; Mortier A; Gouwy M; Ronsse I; Put W; Lenaerts JP; Van Damme J; Proost P
Blood; 2008 Oct; 112(7):2648-56. PubMed ID: 18645041
[TBL] [Abstract][Full Text] [Related]
14. Methods for the detection of peptidylarginine deiminase (PAD) activity and protein citrullination.
Hensen SM; Pruijn GJ
Mol Cell Proteomics; 2014 Feb; 13(2):388-96. PubMed ID: 24298040
[TBL] [Abstract][Full Text] [Related]
15. [Deimination or citrullination, a post-translational modification with many physiological and pathophysiological facets].
Méchin MC; Nachat R; Coudane F; Adoue V; Arnaud J; Serre G; Simon M
Med Sci (Paris); 2011 Jan; 27(1):49-54. PubMed ID: 21299962
[TBL] [Abstract][Full Text] [Related]
16. Biological relevance of citrullinations: diagnostic, prognostic and therapeutic options.
Gudmann NS; Hansen NU; Jensen AC; Karsdal MA; Siebuhr AS
Autoimmunity; 2015 Mar; 48(2):73-9. PubMed ID: 25520183
[TBL] [Abstract][Full Text] [Related]
17. Novel method to quantify peptidylarginine deiminase activity shows distinct citrullination patterns in rheumatoid and juvenile idiopathic arthritis.
Yu K; Dillemans L; Gouwy M; Bessa H; Metzemaekers M; Martens E; Matthys P; Bossuyt X; Verschueren P; Wouters C; De Somer L; Proost P
Front Immunol; 2023; 14():1111465. PubMed ID: 36793709
[TBL] [Abstract][Full Text] [Related]
18. Deimination of myelin basic protein. 2. Effect of methylation of MBP on its deimination by peptidylarginine deiminase.
Pritzker LB; Joshi S; Harauz G; Moscarello MA
Biochemistry; 2000 May; 39(18):5382-8. PubMed ID: 10820009
[TBL] [Abstract][Full Text] [Related]
19. Myelin Basic Protein Citrullination in Multiple Sclerosis: A Potential Therapeutic Target for the Pathology.
Yang L; Tan D; Piao H
Neurochem Res; 2016 Aug; 41(8):1845-56. PubMed ID: 27097548
[TBL] [Abstract][Full Text] [Related]
20. Citrullination regulates pluripotency and histone H1 binding to chromatin.
Christophorou MA; Castelo-Branco G; Halley-Stott RP; Oliveira CS; Loos R; Radzisheuskaya A; Mowen KA; Bertone P; Silva JC; Zernicka-Goetz M; Nielsen ML; Gurdon JB; Kouzarides T
Nature; 2014 Mar; 507(7490):104-8. PubMed ID: 24463520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
